Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals.

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08

Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc (2012) 1.98

Relation of vigorous exercise to risk of atrial fibrillation. Am J Cardiol (2009) 1.79

Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace (2010) 1.50

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace (2011) 1.35

Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace (2008) 1.17

The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study. Eur Heart J (2012) 1.05

Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the β adrenergic system. Front Physiol (2013) 1.03

A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study. Eur J Epidemiol (2014) 0.94

Physical activity and the risk of incident atrial fibrillation in women. Circ Cardiovasc Qual Outcomes (2011) 0.90

Physical activity measured by accelerometry and its associations with cardiac structure and vascular function in young and middle-aged adults. J Am Heart Assoc (2015) 0.90

Reduced incidence of cardiac arrhythmias in walkers and runners. PLoS One (2013) 0.90

Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review. Cardiol Res Pract (2013) 0.90

Losartan prevents heart fibrosis induced by long-term intensive exercise in an animal model. PLoS One (2013) 0.87

Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women. J Am Heart Assoc (2014) 0.87

Increased risk of atrial fibrillation among elderly Norwegian men with a history of long-term endurance sport practice. Scand J Med Sci Sports (2013) 0.86

Increased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNFα. Nat Commun (2015) 0.85

Risk predictors for lone atrial fibrillation. Europace (2008) 0.85

Diagnosis, pathophysiology, and management of exercise-induced arrhythmias. Nat Rev Cardiol (2016) 0.83

Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study. Eur J Epidemiol (2013) 0.83

Emerging risk factors and the dose-response relationship between physical activity and lone atrial fibrillation: a prospective case-control study. Europace (2015) 0.82

Almanac 2015: atrial fibrillation research in Heart. Heart (2016) 0.80

Genetic variants related to height and risk of atrial fibrillation: the cardiovascular health study. Am J Epidemiol (2014) 0.80

Atrial fibrillation and long-term sports practice: epidemiology and mechanisms. Clin Res Cardiol (2014) 0.79

The association between job strain and atrial fibrillation in Swedish men. Occup Environ Med (2014) 0.79

Risk factors between patients with lone and non-lone atrial fibrillation. J Korean Med Sci (2013) 0.79

Early life predictors of atrial fibrillation-related mortality: evidence from the health and retirement study. Health Place (2013) 0.76

Evaluating the benefits of home-based management of atrial fibrillation: current perspectives. Pragmat Obs Res (2016) 0.75

Endurance Sport Activity and Risk of Atrial Fibrillation - Epidemiology, Proposed Mechanisms and Management. Arrhythm Electrophysiol Rev (2014) 0.75

Atrial Fibrillation In Athletes: Pathophysiology, Clinical Presentation, Evaluation and Management. J Atr Fibrillation (2015) 0.75

Chronic exercise: a contributing factor to atrial fibrillation? J Am Coll Cardiol (2013) 0.75

Endurance Sport Practice and Atrial Fibrillation. J Atr Fibrillation (2010) 0.75

Lone Atrial Fibrillation: Risk Factors, Triggers And Ablation Techniques. J Atr Fibrillation (2015) 0.75

Atrial Fibrillation in Athletes - The Story Behind The Running Hearts. J Atr Fibrillation (2010) 0.75

Atrial fibrillation and physical activity: Should we exercise caution? Can Fam Physician (2015) 0.75

Lean body mass and risk of incident atrial fibrillation in post-menopausal women. Eur Heart J (2015) 0.75

Assessment of the p wave dispersion and duration in elite women basketball players. Indian Pacing Electrophysiol J (2010) 0.75

[Palpitations in competitive athletes. Risks from premature beats, nonsustained tachycardia and preexcitation]. Herz (2009) 0.75

Arrhythmias in the athlete. Herzschrittmacherther Elektrophysiol (2012) 0.75

Cardiac damage in athlete's heart: When the "supernormal" heart fails! World J Cardiol (2017) 0.75

Atrial fibrillation in two adolescents. Pediatr Cardiol (2012) 0.75

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10

Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation (2005) 8.76

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm (2012) 8.03

Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med (2013) 7.35

HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm (2007) 7.20

Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet (2010) 7.08

A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet (2009) 6.31

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace (2012) 5.84

New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet (2009) 5.12

An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm (2009) 4.99

Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med (2014) 4.94

HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm (2013) 4.62

A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med (2015) 4.17

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07

Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies). J Am Coll Cardiol (2013) 4.03

Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation (2002) 3.76

Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation (2010) 3.72

Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation (2003) 3.68

Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation (2011) 3.00

HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace (2007) 2.87

Carotid intima-media thickness in the Spanish population: reference ranges and association with cardiovascular risk factors. Rev Esp Cardiol (Engl Ed) (2012) 2.78

Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion. Circulation (2011) 2.61

Ambient air pollution is associated with increased risk of hospital cardiac readmissions of myocardial infarction survivors in five European cities. Circulation (2005) 2.58

Brugada syndrome: report of the second consensus conference. Heart Rhythm (2005) 2.48

Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr (2006) 2.47

Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysiol (2003) 2.44

De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res (2005) 2.27

Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report. J Electrocardiol (2012) 2.26

Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol (2010) 2.17

Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet (2002) 2.16

New electrocardiographic diagnostic criteria for the pathologic R waves in leads V1 and V2 of anatomically lateral myocardial infarction. J Electrocardiol (2008) 2.15

Effect of opening a new catheterization laboratory on 30-day and 2-year survival rates in myocardial infarction patients. Rev Esp Cardiol (2011) 2.14

Familial pseudo-Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol (2006) 2.11

IntOGen-mutations identifies cancer drivers across tumor types. Nat Methods (2013) 2.10

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08

Incidence and risk factors of peripheral arterial occlusive disease in a prospective cohort of 700 adult elderly men followed for 5 years. World J Surg (2010) 2.06

Electrocardiographic recognition of the epicardial origin of ventricular tachycardias. Circulation (2004) 2.05

The European cardiac resynchronization therapy survey. Eur Heart J (2009) 2.04

Cardiac resynchronization therapy in patients with permanent atrial fibrillation. Is it mandatory to ablate the atrioventricular junction to obtain a good response? Eur J Heart Fail (2012) 2.04

Complete atrioventricular block does not reduce long-term mortality in patients with permanent atrial fibrillation treated with cardiac resynchronization therapy. Eur J Heart Fail (2013) 2.03

Brugada syndrome. Rev Esp Cardiol (2009) 2.03

Nonsurgical transthoracic epicardial radiofrequency ablation: an alternative in incessant ventricular tachycardia. J Am Coll Cardiol (2003) 1.97

Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace (2013) 1.97

Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation (2011) 1.96

Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation (2005) 1.94

Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm (2009) 1.92

Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J (2007) 1.86

[Coronary risk estimation in Spain using a calibrated Framingham function]. Rev Esp Cardiol (2003) 1.85

Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J (2013) 1.83

Cryptic 5' splice site activation in SCN5A associated with Brugada syndrome. J Mol Cell Cardiol (2004) 1.81

Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias. Circulation (2008) 1.81

HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm (2008) 1.79

Assessment of mitral valve anatomy and geometry with multislice computed tomography. JACC Cardiovasc Imaging (2009) 1.75

Assessment of left ventricular dyssynchrony by real-time three-dimensional echocardiography. Rev Esp Cardiol (2008) 1.74

[Epidemiology of ischaemic heart disease in Spain: estimation of the number of cases and trends from 1997 to 2005]. Rev Esp Cardiol (2002) 1.73

HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association. Europace (2008) 1.70

Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A:. J Cardiovasc Electrophysiol (2004) 1.69

Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr (2010) 1.69

Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace (2008) 1.68

Gender differences in clinical manifestations of Brugada syndrome. J Am Coll Cardiol (2008) 1.67

Left atrial sphericity: a new method to assess atrial remodeling. Impact on the outcome of atrial fibrillation ablation. J Cardiovasc Electrophysiol (2013) 1.67

A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. Circ Cardiovasc Genet (2011) 1.63

Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial. Eur Heart J (2009) 1.63

Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur Heart J (2003) 1.63

State of the art in forensic investigation of sudden cardiac death. Am J Forensic Med Pathol (2011) 1.61

Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace (2010) 1.61

Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace (2008) 1.57

Survival in New York Heart Association class IV heart failure patients treated with cardiac resynchronization therapy compared with patients on optimal pharmacological treatment. Europace (2010) 1.55

Epicardial ablation for ventricular tachycardia: a European multicenter study. Circ Arrhythm Electrophysiol (2011) 1.55